Changes in Gene Transcription Underlying the Aberrant Citrate and Choline Metabolism in Human Prostate Cancer Samples

Clinical Cancer Research, 05/17/2012

By integrating histologic, transcriptomic, and metabolic data, the study has contributed to an expanded understanding of the mechanisms underlying aberrant citrate and choline–containing compounds (ChoCC) levels in prostate cancer.

Print Article Summary Cat 2 CME Report